Carcinogenesis, Vol. 22, No. 5, 757-762,
May 2001
© 2001 Oxford University Press
CARCINOGENESIS |
Mechanisms of Cr(VI)-induced p53 activation: the role of phosphorylation, mdm2 and ERK
Pathology and Physiology Research Branch, Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Morgantown, WV 26505, Department of Basic Pharmaceutical Sciences, West Virginia University, Morgantown, WV 26506, USA
The present study investigated the molecular mechanisms of p53 activation induced by Cr(VI), using human lung epithelial A549 cells. Cr(VI) increased both protein level and transactivation ability of p53 protein. The activation of p53 is at the protein level instead of the transcriptional level. The degradation of p53 was dramatically decreased upon stimulation by Cr(VI). In addition, Cr(VI) treatment decreased the interaction of p53 with mdm2 protooncoprotein, which blocks the transactivation ability of p53 and promotes the degradation of p53 protein. In response to Cr(VI) treatment, p53 protein became phosphorylated and acetylated at Ser15 and Lys382, respectively. The phosphorylation levels at either Ser20 or Ser392 did not show any significant alterations. Since previous studies report that it is Ser20 and not Ser15 phosphorylation that contributes to mdm2 dissociation from p53, the results obtained from the current investigation suggest a different mechanism: Ser15 instead of Ser20 may play a key role in the dissociation of mdm2 in response to Cr(VI). Erk, a member of mitogen-activated protein kinase, acts as the upstream kinase for the phosphorylation of the p53 Ser15 site.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  N. Li, Y. Zheng, W. Chen, C. Wang, X. Liu, W. He, H. Xu, and X. Cao Adaptor Protein LAPF Recruits Phosphorylated p53 to Lysosomes and Triggers Lysosomal Destabilization in Apoptosis Cancer Res., December 1, 2007; 67(23): 11176 - 11185. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Reynolds and A. Zhitkovich Cellular vitamin C increases chromate toxicity via a death program requiring mismatch repair but not p53 Carcinogenesis, July 1, 2007; 28(7): 1613 - 1620. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. J. Mukherjee and H. C. Sikka Attenuation of BPDE-induced p53 accumulation by TPA is associated with a decrease in stability and phosphorylation of p53 and downregulation of NF{kappa}B activation: role of p38 MAP kinase Carcinogenesis, March 1, 2006; 27(3): 631 - 638. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Brown and S. Benchimol The Involvement of MAPK Signaling Pathways in Determining the Cellular Response to p53 Activation: CELL CYCLE ARREST OR APOPTOSIS J. Biol. Chem., February 17, 2006; 281(7): 3832 - 3840. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Russo, A. Catassi, A. Cesario, A. Imperatori, N. Rotolo, M. Fini, P. Granone, and L. Dominioni Molecular Mechanisms of Hexavalent Chromium-Induced Apoptosis in Human Bronchoalveolar Cells Am. J. Respir. Cell Mol. Biol., December 1, 2005; 33(6): 589 - 600. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Peterson-Roth, M. Reynolds, G. Quievryn, and A. Zhitkovich Mismatch Repair Proteins Are Activators of Toxic Responses to Chromium-DNA Damage Mol. Cell. Biol., May 1, 2005; 25(9): 3596 - 3607. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Majumder, K. Ghoshal, D. Summers, S. Bai, J. Datta, and S. T. Jacob Chromium(VI) Down-regulates Heavy Metal-induced Metallothionein Gene Transcription by Modifying Transactivation Potential of the Key Transcription Factor, Metal-responsive Transcription Factor 1 J. Biol. Chem., July 3, 2003; 278(28): 26216 - 26226. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Ha, S. Ceryak, and S. R. Patierno Chromium (VI) Activates Ataxia Telangiectasia Mutated (ATM) Protein. REQUIREMENT OF ATM FOR BOTH APOPTOSIS AND RECOVERY FROM TERMINAL GROWTH ARREST J. Biol. Chem., May 9, 2003; 278(20): 17885 - 17894. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Gao, B.-H. Jiang, S. S. Leonard, L. Corum, Z. Zhang, J. R. Roberts, J. Antonini, J. Z. Zheng, D. C. Flynn, V. Castranova, et al. p38 Signaling-mediated Hypoxia-inducible Factor 1alpha and Vascular Endothelial Growth Factor Induction by Cr(VI) in DU145 Human Prostate Carcinoma Cells J. Biol. Chem., November 15, 2002; 277(47): 45041 - 45048. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. D'Agostini, A. Izzotti, C. Bennicelli, A. Camoirano, E. Tampa, and S. De Flora Induction of apoptosis in the lung but not in the liver of rats receiving intra-tracheal instillations of chromium(VI) Carcinogenesis, April 1, 2002; 23(4): 587 - 593. [Abstract] [Full Text] [PDF]
|
|